Human Fibroblasts with Mutations in COL5A1 and COL3A1 Genes Do Not Organize Collagens and Fibronectin in the Extracellular Matrix, Down-regulate α2β1 Integrin, and Recruit αvβ3 Instead of α5β1 Integrin
Open accessAbstract
Dermal fibroblasts derived from types I and IV Ehlers-Danlos syndrome (EDS) patients, carrying mutations in COL5A1 and COL3A1 genes, respectively, synthesize aberrant types V and III collagen (COLL) and show defective organization of these proteins into the extracellular matrix (ECM) and high reduction of their functional receptor, the alpha(2)beta(1) integrin, compared with control fibroblasts. EDS cells also show reduced levels of fibronectin (FN) in the culture medium and lack an FN fibrillar network. Finally, EDS cells prevalently organize alpha(v)beta(3) integrin instead of alpha(5)beta(1) integrin. The alpha(v)beta(3) integrin, distributed on the whole EDS cell surface, shows FN binding and assembly properties when the cells are treated with purified FN. Treatment of EDS cells with purified COLLV or COLLIII, but not with FN, restores the control phenotype (COLL(+), FN(+), alpha(v)beta(3)(-), alpha(5)beta(1)(+), alpha(2)beta(1)(+)). Function-blocking antibodies to COLLV, COLLIII, or alpha(2)beta(1) integrin induce in control fibroblasts an EDS-like phenotype (COLL(-), FN(-), alpha(v)beta(3)(+), alpha(5)beta(1)(-), alpha(2)beta(1)(-)). These results show that in human fibroblasts alpha(2)beta(1) integrin organization and function are controlled by its ligand, and that the alpha(2)beta(1)-COLL interaction, in turn, regulates FN integrin receptor recruitment: high alpha(2)beta(1) integrin levels induce alpha(5)beta(1) integrin organization, while low alpha(2)beta(1) integrin levels lead to alpha(v)beta(3) integrin organization.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Decreased expression of periostin encoded by POSTN in cEDS fibroblasts may contribute to the generalized ECM disarray and in vitro poor wound healing.
“In cEDS fibroblasts, the decreased expression of periostin encoded by POSTN may also contribute to the generalized ECM disarray and in vitro poor wound healing [44,48].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [44]
cEDS cells exhibit a crosstalk involving the αvβ3 integrin and EGF receptor that rescues them from anoikis.
“cEDS cells also exhibit a reduced in vitro migration capability, an abnormal wound healing response, and a crosstalk involving the αvβ3 integrin and epidermal growth factor (EGF) receptor that rescues them from anoikis [44,45,46,47,48,49,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [44]
cEDS cells exhibit an abnormal wound healing response.
“cEDS cells also exhibit a reduced in vitro migration capability, an abnormal wound healing response, and a crosstalk involving the αvβ3 integrin and epidermal growth factor (EGF) receptor that rescues them from anoikis [44,45,46,47,48,49,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [44]
cEDS patients' fibroblasts show disassembly of many ECM components, including collagen V and III, fibronectin, and fibrillins.
“Our in vitro findings demonstrated that cEDS patients’ fibroblasts show disassembly of many ECM components, including collagen V and III, fibronectin, and fibrillins, and disorganization of collagen- and fibronectin-specific α2β1 and α5β1 integrin receptors [44,45,46,47].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [44]
cEDS patients' fibroblasts show disorganization of collagen- and fibronectin-specific α2β1 and α5β1 integrin receptors.
“Our in vitro findings demonstrated that cEDS patients’ fibroblasts show disassembly of many ECM components, including collagen V and III, fibronectin, and fibrillins, and disorganization of collagen- and fibronectin-specific α2β1 and α5β1 integrin receptors [44,45,46,47].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [44]
cEDS cells exhibit reduced in vitro migration capability.
“cEDS cells also exhibit a reduced in vitro migration capability, an abnormal wound healing response, and a crosstalk involving the αvβ3 integrin and epidermal growth factor (EGF) receptor that rescues them from anoikis [44,45,46,47,48,49,50].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [44]
hEDS/HSD, cEDS, and vEDS fibroblasts exhibit marked disorganization of collagen and fibronectin ECM and their specific α2β1 and α5β1 integrin receptors and show preferential expression of the αvβ3 integrin.
“In particular, hEDS/HSD, cEDS, and vEDS fibroblasts exhibit a marked disorganization of collagen and fibronectin ECM and their specific α2β1 and α5β1 integrin receptors and showed the preferential expression of the αvβ3 integrin [44,49,50,123].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [44]
Dominant negative mutations in COL3A1 lead to reduced secretion of collagen I into the ECM in cultured patients' fibroblasts.
“Our previous protein findings on cultured patients’ fibroblasts showed that dominant negative mutations in COL3A1 lead to the reduced secretion of collagen I into the ECM [44], consistent with the known regulatory role of collagen III in synthesis and deposition of heterotypic fibrils that largely contain collagen I [96].”
From Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes (2019) · cites this paper as [44]
Expression of αvβ3 integrin is a shared feature of all EDS fibroblast types.
“but express the αvβ3 integrin that is a common trait of all types of EDS fibroblasts [8][9][10][11][12].”
Control fibroblasts do not express αvβ3 integrin under standard growth conditions but organize it preferentially in focal adhesions with hEDS/HSD conditioned medium.
“Furthermore, the evidence that control fibroblasts, which do not express this integrin in standard growth conditions ( [9,10], this work), organize it preferentially in focal adhesions in the presence of hEDS and HSD CM corroborates the involvement of αvβ3 integrin in focal contacts in the transdifferentiation of fibroblasts into myofibroblasts.”
Cultured skin fibroblasts of vEDS patients synthesize aberrant COLLIII that is not organized into the ECM as well as COLLI and fibronectin.
“Cultured skin fibroblasts of vEDS patients synthesize aberrant COLLIII that is not organized into the extracellular matrix (ECM) as well as COLLI and fibronectin (FN) [16,17].”
Our protein data indicated the disorganization of the core proteins of PGs perlecan, versican, and DCN, and their abnormal organization could contribute to the defective COLLIII fibril assembly in vEDS cells, as well as to the defective fibrillogenesis of other COLLs.
“Our protein data indicated the disorganization of the core proteins of PGs perlecan, versican, and DCN, which enhance COLL fibril formation [26], and their abnormal organization could contribute to the defective COLLIII fibril assembly in vEDS cells, as well as to the defective fibrillogenesis of other COLLs previously described in skin fibroblasts of different EDS types and in other connective”
In vEDS patients' skin fibroblasts, abnormal synthesis and deposition of COLLIII into the ECM together with disarray of FN and lack of COLLs- and FN-specific integrin receptors were previously demonstrated.
“In vEDS patients’ skin fibroblasts, we previously demonstrated an abnormal synthesis and deposition of COLLIII into the ECM together with the disarray of FN and the lack of COLLs- and FN-specific integrin receptors [16,17].”
In the present study, the abnormal folding, secretion, and ECM organization of COLLIII cause an altered deposition and disassembly of other structural constituents, such as FN, FBNs, ELN, and EMILINs.
“In the present study, we demonstrated that the abnormal folding, secretion, and ECM organization of COLLIII cause an altered deposition and the disassembly of other structural constituents, such as FN, FBNs, ELN, and EMILINs [16,25], which provide a scaffold for elastogenesis and represent the major components of elastic fibers in elastic tissues including skin and arterial walls, and are essent”
In vEDS skin fibroblasts, defective synthesis of COLLIII did not interfere with COLLV secretion and its extracellular organization, but altered the deposition and proper assembly into the ECM of COLLI, which was mainly retained in the cytoplasm.
“We previously showed that in vEDS skin fibroblasts the defective synthesis of COLLIII did not interfere with the COLLV secretion and its extracellular organization, but altered the deposition and proper assembly into the ECM of COLLI, which was mainly retained in the cytoplasm [16].”
Structural mutations in genes encoding for different COLLs, i.e., COLLI, COLLIII, and COLLV, affect not only the assembly but also the secretion pathways of other ECM components in EDS fibroblasts.
“according to the notion that structural mutations in genes encoding for different COLLs, i.e., COLLI, COLLIII, and COLLV, affect not only the assembly but also the secretion pathways of other ECM components in EDS fibroblasts [16,17,33].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 60 · Cited by 107
Research works printed but not linked: 6
- Kielty, C. M., Hopkinson, I., and Grant, M. E. (1993) in Connective Tissue and Its Heritable Disorders: Molecular Genetics and Medical Aspects (Royce P. M., and Steinmann B., eds) pp. 103-147, Wiley-Liss, New York
- Steinmann, B., and Superti-Furga, A. (1993) in Connective Tissue and Its Heritable Disorders: Molecular Genetics and Medical Aspects (Royce P. M., and Steinmann B., eds) pp. 351-407, Wiley-Liss, New York
- Colvin, R. B. (1989) in Fibronectin (Mosher D. F., ed) pp. 213-254, Academic Press Inc., San Diego
- Thie ´ry, J., Duband, J., Dufour, S., Savagner, P., and Imhof, B. A. (1989) in Fibronectin (Mosher D. F., ed) pp. 181-212, Academic Press Inc., San Diego
- Byers, P. H. (1990) in Extracellular Matrix Genes (Sandell, L. J., and Boyd, C. D., eds) pp. 251-263, Academic Press Inc., San Diego
- Zhang, Z., Vuori, K., Reed, J. C., and Ruoslahti E. (1995) Proc. Natl. Acad. Sci.
- Authors
- Zoppi, N., Gardella, R., De Paepe, A., Barlati, S., & Colombi, M.
- Affiliations
- University of Brescia (IT)
- Corresponding author
- Colombi, Marina
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 18
- Pages
- 18157-18168
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082154271
- Cited by
- 107
- References
- 60
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 10 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 4 · 2019: 11 · 2018: 5 · 2017: 3 · 2016: 6 · 2015: 4 · 2014: 5 · 2013: 6 · 2012: 9
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by)
- Funders
- Fondazione Cariplo
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Keywords
- Ehlers-Danlos syndrome, COL5A1, COL3A1, type V collagen, type III collagen, dermal fibroblasts, extracellular matrix organization, fibronectin, alpha2beta1 integrin, alpha5beta1 integrin, integrin αvβ3, collagen synthesis
- MeSH terms
- Adolescent, Cells, Cultured, Collagen, Ehlers-Danlos Syndrome, Extracellular Matrix, Fibroblasts, Fibronectins, Humans, Mutation, Down-Regulation, Integrins, Collagen Type III, Collagen Type V, Integrin alpha2beta1, Integrin alpha5beta1, Integrin alphaVbeta3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review